Canada Cannabis Law

Canada was the first G7 nation to federally legalize adult-use cannabis in 2018 under the Cannabis Act. Health Canada administers a rigorous licensing regime for cultivation, processing, and retail — creating a complex regulatory environment that has shaped MSO strategy globally. The Act's export framework allows licensed producers to ship cannabis internationally for medical purposes, making Canada the de facto hub for cross-border cannabis supply chains.

Bob Hoban has advised Canadian licensed producers on US market entry strategies, assisted US MSOs evaluating Canadian acquisition targets, and counseled US investors on Canadian capital markets compliance. Key hot topics include LP consolidation and distressed M&A, Health Canada's Good Production Practices amendments, provincial retail control models, and the evolving export framework to jurisdictions in Europe and Asia Pacific.

Critical areas of advisory focus include section 56 exemptions for research, the micro-cultivation licence pathway, and treaty compliance when Canadian operators engage US capital.